Isotopically labelledTeriflunomide-D4Cat. No. P-T062-002CAS 1185240-22-5Family · Pharmaceutical analytical standards
Teriflunomide
An immunomodulator that blocks the enzyme dihydroorotate dehydrogenase, slowing the de novo synthesis of pyrimidines, building blocks of DNA and RNA: it was approved in the US in 2012 and in the European Union in 2013 for multiple sclerosis. This family brings together labelled standards, nitrosamines and other impurities.
Did you know?It is the main active metabolite of leflunomide, an older drug: about 70% of leflunomide turns into teriflunomide in the body, simply by the opening of an isoxazole ring.
Isotopically labelledTeriflunomide-D4Cat. No. P-T062-002CAS 1185240-22-5
NitrosamineN-Nitroso TeriflunomideCat. No. P-T062-003
ImpurityTeriflunomide Impurity 1Cat. No. P-T062-004CAS 69066-42-8
ImpurityTeriflunomide Impurity 2Cat. No. P-T062-005CAS 3788-94-1
ImpurityTeriflunomide Impurity 3Cat. No. P-T062-006
ImpurityTeriflunomide Lactose Adduct 1Cat. No. P-T062-007
ImpurityTeriflunomide Lactose Adduct 2Cat. No. P-T062-008
ImpurityTeriflunomide-E IsomerCat. No. P-T062-009CAS 214782-56-6No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceTeriflunomide CRSEDQM code Y0002247Family TeriflunomideReference substanceTeriflunomide for assay CRSEDQM code Y0002253Family Teriflunomide
ImpurityTeriflunomide impurity B CRSEDQM code Y0002254Family TeriflunomideNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.